540975 Panoramica delle azioni Aster DM Healthcare Limited, insieme alle sue consociate, fornisce servizi di assistenza sanitaria e servizi correlati in India, Emirati Arabi Uniti, Qatar, Oman, Regno dell'Arabia Saudita, Giordania, Kuwait e Bahrain, e Repubblica di Mauritius. Maggiori dettagli
Premi Analisi del rischio Vedi tutti gli assegni di rischio Catturate i vostri pensieri, i link e la narrativa aziendale
Aster DM Healthcare Limited Concorrenti Storia dei prezzi e prestazioni
Riepilogo dei massimi, dei minimi e delle variazioni dei prezzi delle azioni per Aster DM Healthcare Prezzi storici delle azioni Prezzo attuale dell'azione ₹486.85 Massimo di 52 settimane ₹558.30 Minimo di 52 settimane ₹312.25 Beta 0.62 Variazione di 1 mese 12.31% Variazione a 3 mesi 15.52% Variazione di 1 anno 23.00% Variazione a 3 anni 183.22% Variazione a 5 anni 214.00% Variazione dall'IPO 156.24%
Notizie e aggiornamenti recenti
Price target increased by 12% to ₹551 Dec 03 Aster DM Healthcare Limited announced that it expects to receive funding from BCP Asia II Topco Iv PTE. Ltd., Centella Mauritius Holdings Limited Nov 30
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into a Share Purchase Agreement to acquire 13% stake in Prerana Hospital Limited. Nov 27
Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap Nov 11
Price target increased by 9.1% to ₹463 Oct 25
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Oct 24 Vedi altri aggiornamenti
Price target increased by 12% to ₹551 Dec 03 Aster DM Healthcare Limited announced that it expects to receive funding from BCP Asia II Topco Iv PTE. Ltd., Centella Mauritius Holdings Limited Nov 30
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into a Share Purchase Agreement to acquire 13% stake in Prerana Hospital Limited. Nov 27
Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap Nov 11
Price target increased by 9.1% to ₹463 Oct 25
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Oct 24
Aster DM Healthcare Limited to Report Q2, 2025 Results on Oct 23, 2024 Oct 17
Aster DM Healthcare Appoints Mohamed Alshamari as CEO of Aster Hospitals and Clinics in Saudi Arabia Oct 08 Aster DM Healthcare and Quality CARE Reportedly in Final Stages of Negotiations and Expects Deal to be Sign by the End of September 2024
Aster DM Healthcare Limited Announces Executive Changes Sep 11
High number of new directors Sep 10 Aster DM Healthcare Limited Approves Board Appointments
Upcoming dividend of ₹2.00 per share Aug 15
Blackstone Reportedly in Talks with the Promoters of Aster DM Healthcare to Merge Quality Care India with Aster Aug 06
First quarter 2025 earnings released: EPS: ₹1.49 (vs ₹0.10 in 1Q 2024) Aug 01
Aster DM Healthcare Limited to Report Q1, 2025 Results on Jul 31, 2024 Jul 25 Olympus Capital Asia Investments to Sell Up to 10% Stake in Aster DM Healthcare through Block Deals Jun 21
Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024 May 31
New minor risk - Dividend sustainability May 31
Price target decreased by 7.3% to ₹453 May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 29
Full year 2024 earnings released: EPS: ₹2.46 (vs ₹8.54 in FY 2023) May 29
Aster DM Healthcare Limited to Report Q4, 2024 Results on May 28, 2024 May 24 Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel
New minor risk - Share price stability Apr 23
Investor sentiment deteriorates as stock falls 23% Apr 23
Aster DM Healthcare Limited Declares Special Dividend Apr 13
Aster DM Healthcare Limited Declares Special Dividend Apr 12
Investor sentiment improves as stock rises 19% Apr 08
Aster DM Healthcare Limited Announces Board Changes Apr 03
Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare Mar 27
Price target increased by 9.3% to ₹459 Feb 12
New major risk - Financial position Feb 12
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Feb 09
Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024 Feb 03
Now 20% undervalued Jan 01
KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare Dec 13
Aster DM Healthcare to Fuel India Expansion Through Buyouts Dec 08
New minor risk - Share price stability Dec 01
Price target increased by 18% to ₹397 Nov 30
Investor sentiment improves as stock rises 17% Nov 29
Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023) Nov 15
Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion Oct 12
New major risk - Financial position Aug 17
Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director Aug 15
Full year 2023 earnings: EPS misses analyst expectations Aug 10
Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 08
Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023 Aug 04
Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business Jul 08
Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business Jul 06
Investor sentiment improves as stock rises 16% Jul 04
Price target increased by 7.6% to ₹291 May 29
Aster Eye $300 million India Stake Sale May 27
Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022) May 26
Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director May 25
Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023 May 20
Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022) Feb 15
Aster DM Healthcare Limited Appoints Rahul Kadavakolu as Group Chief Marketing Officer Feb 10
Aster DM Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 09
Aster DM Healthcare Limited Announces Resignation of Sreenath Pocha Reddy as Group Chief Financial Officer, Effective 5 January 2023 Jan 06
Price target increased to ₹275 Nov 16
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
Less than half of directors are independent Nov 16
Aster DM Healthcare Limited Announces Retirement of Prof. Biju Varkkey as Non-Executive Independent Director Nov 12
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 11
Aster DM Healthcare Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 05
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into share purchase agreement to acquire 22.69% stake in Sri SaiNatha Multi Speciality Hospitals Pvt. Ltd from promoters and their relatives for INR 250 million. Oct 21
Investor sentiment improved over the past week Sep 08
Aster DM Healthcare Limited to Report Q1, 2023 Results on Aug 11, 2022 Aug 07
Full year 2022 earnings: EPS and revenues exceed analyst expectations Aug 04
Investor sentiment improved over the past week Jul 19
Investor sentiment improved over the past week May 31
Aster DM Healthcare Limited, Annual General Meeting, Aug 25, 2022 May 25
Full year 2022 earnings: EPS and revenues exceed analyst expectations May 25
Aster DM Healthcare Limited to Report Q4, 2022 Results on May 24, 2022 May 17
Less than half of directors are independent Apr 27
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Feb 09
Aster DM Healthcare Limited to Report Q3, 2022 Results on Feb 08, 2022 Feb 03
Price target increased to ₹232 Nov 30
Second quarter 2022 earnings released: EPS ₹2.15 (vs ₹0.66 in 2Q 2021) Nov 12
Non-Executive Independent Director Suresh Kumar has left the company Sep 19
Price target increased to ₹210 Sep 03
Investor sentiment improved over the past week Sep 01
Investor sentiment improved over the past week Aug 18
Full year 2021 earnings released: EPS ₹2.97 (vs ₹5.51 in FY 2020) Jul 24
Aster DM Healthcare Limited entered into an agreement to acquire a 86% stake in Hindustan Drug House for approximately INR 167 million. Jun 30
Full year 2021 earnings released: EPS ₹2.97 (vs ₹5.51 in FY 2020) Jun 25 Rendimenti per gli azionisti 540975 IN Healthcare IN Mercato 7D 1.4% -1.3% -4.2% 1Y 23.0% 41.8% 19.1%
Vedi i rendimenti completi degli azionisti
Ritorno vs Industria: 540975 ha avuto una performance inferiore rispetto al Indian Healthcare che ha registrato un rendimento 41.8 % nell'ultimo anno.
Rendimento vs Mercato: 540975 ha eguagliato il mercato Indian che ha restituito 19.1 % nell'ultimo anno.
Volatilità dei prezzi Is 540975's price volatile compared to industry and market? 540975 volatility 540975 Average Weekly Movement 5.0% Healthcare Industry Average Movement 5.7% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Prezzo delle azioni stabile: 540975 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.
Volatilità nel tempo: La volatilità settimanale ( 5% ) di 540975 è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda Aster DM Healthcare Limited, insieme alle sue consociate, fornisce servizi sanitari e di assistenza in India, Emirati Arabi Uniti, Qatar, Oman, Regno dell'Arabia Saudita, Giordania, Kuwait e Bahrein e Repubblica di Mauritius. Opera attraverso i segmenti Ospedali, Cliniche, Farmacie al dettaglio e Altri. La società gestisce ospedali e farmacie interne agli ospedali, cliniche e farmacie interne alle cliniche, nonché farmacie al dettaglio e online e punti vendita di ottica.
Mostra di più Aster DM Healthcare Limited Riepilogo dei fondamenti Come si confrontano gli utili e i ricavi di Aster DM Healthcare con la sua capitalizzazione di mercato? 540975 statistiche fondamentali Capitalizzazione di mercato ₹242.09b Guadagni(TTM ) ₹2.26b Ricavi(TTM ) ₹40.17b
Guadagni e ricavi Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM) 540975 Conto economico (TTM ) Ricavi ₹40.17b Costo del fatturato ₹17.95b Profitto lordo ₹22.21b Altre spese ₹19.95b Guadagni ₹2.26b
Ultimi guadagni dichiarati
Sep 30, 2024
Prossima data di guadagno
n/a
Utile per azione (EPS) 4.54 Margine lordo 55.31% Margine di profitto netto 5.63% Rapporto debito/patrimonio netto 16.4%
Come si è comportato 540975 nel lungo periodo?
Vedi performance storica e confronto Dividendi
0.4% Rendimento attuale del dividendo
81% Rapporto di remunerazione
Analisi aziendale e situazione dei dati finanziari Dati Ultimo aggiornamento (ora UTC) Analisi dell'azienda 2024/12/20 05:23 Prezzo dell'azione a fine giornata 2024/12/20 00:00 Guadagni 2024/09/30 Guadagni annuali 2024/03/31
Fonti dei dati I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC . I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
Pacchetto Dati Tempistica Esempio Fonte USA * Dati finanziari della società 10 anni Conto economico Rendiconto finanziario Bilancio Stime di consenso degli analisti +3 anni Previsioni finanziarie Obiettivi di prezzo degli analisti Prezzi di mercato 30 anni Prezzi delle azioni Dividendi, scissioni e azioni Proprietà 10 anni Top azionisti Insider trading Gestione 10 anni Team di leadership Consiglio di amministrazione Sviluppi principali 10 anni
* esempio per i titoli statunitensi, per quelli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più , cliccate qui .
Modello di analisi e Snowflake I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github ; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube .
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su .
Fonti analitiche Aster DM Healthcare Limited è coperta da 19 analisti. 9 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
Analista Istituzione Vijayaraghavan Swaminathan Avendus Spark Harith Ahamed Avendus Spark Kunal Randeria Axis Capital Limited
Mostra 16 altri analisti 
